clinical trial · NCT06633536
Real-life Treatment Outcomes of Ravulizumab in PNH
AstraZeneca·—·active not recruiting·n = 64
Paroxysmal Nocturnal HaemoglobinuriaRavulizumab
brief summary
The PNH-RECORD study, a Polish multicenter observational (non-interventional), open-label, retrospective with prospective follow-up.
started
Feb 6, 2025
primary completion
Aug 1, 2028
completion
Aug 1, 2028
last updated
Apr 1, 2026
detailed description
PNH-RECORD study aims to aims to collect data on the patients' characteristics and clinical outcomes of ravulizumab administered in the scope of routine clinical practice in PNH.
official title
Real-life Treatment Outcomes of Ravulizumab in Polish Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH). Prospective and Retrospective, Multicenter, Non-interventional Study.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol